Automated vs Manual Polysomnography Scoring in Adults With Obstructive Sleep Apnea

NCT07826143 | Not Yet Recruiting

• 1 other identifier: FMASU MD 129/2026
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This prospective study aims to compare automated polysomnographic scoring with manual scoring in adult patients with Obstructive Sleep Apnea (OSA). The main objective is to evaluate the accuracy, reliability, and time efficiency of automated scoring algorithms compared to standard manual scoring performed by expert sleep specialists

Conditions

Obstructive Sleep Apnea

Keywords

Automated Scoring; Polysomnography

Outcome Measures

Primary Outcomes (1)

• Apnea-Hypopnea Index (AHI) Agreement

  Comparison of the Apnea-Hypopnea Index (AHI) values obtained from automated polysomnographic scoring against those obtained from manual scoring.

  At the time of sleep study completion (1 night)

Study Arms (1)

Adult OSA Patients

Adult patients diagnosed with Obstructive Sleep Apnea undergoing polysomnography to compare automated versus manual scoring.

Diagnostic Test: Polysomnographic Scoring (Automated vs. Manual)

Interventions

Polysomnographic Scoring (Automated vs. Manual) DIAGNOSTIC_TEST

Comparison between automated scoring software and standard manual scoring by expert specialists for sleep study records.

Adult OSA Patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients referred to the sleep unit with suspected OSA who are scheduled for an overnight diagnostic PSG.

You may qualify if:

• Age \> 18 years.
• Clinical suspicion of OSA based on history, physical examination, and a positive screening questionnaire (e.g., STOP-BANG ≥ 3).
• Ability to provide written informed consent.

You may not qualify if:

• Age ≤ 18 years.
• Inability to give informed consent (e.g., severe cognitive impairment, language barrier).
• Contraindications to PSG (e.g., severe skin conditions preventing electrode placement).
• Current use of therapies that could alter sleep architecture (e.g., highdose benzodiazepines, opioids) unless a wash-out period is observed.

Sponsors & Collaborators

• Ain Shams University: lead

Study Sites (1)

Ain shams university hospitals

Cairo, Cairo Governorate, Egypt

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea Syndromes; Apnea; Respiration Disorders; Respiratory Tract Diseases; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases

Study Officials

• Amira Elghonemy, MD candidate

  Ain Shams University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Amira Elghonemy, MD Candidate

CONTACT

+201032438035; amiraelghonemy07@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 13, 2026
• First Posted: September 17, 2026
• Study Start (Estimated): February 1, 2027
• Primary Completion (Estimated): February 1, 2028
• Study Completion (Estimated): February 1, 2028
• Last Updated: September 23, 2026

Record last verified: 2026-09

Locations

EG (1)